Clinical Trials Browser

Phase 3 × Carcinoma × regorafenib × Clear all

NCT04879368 2025-07-17

INTEGRATEIIb

Phase 3 Active not recruiting

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT02773524 2022-01-13

INTEGRATEIIa

Phase 3 Unknown

Adenocarcinoma, Carcinoma, Neoplasm Metastasis